Shaping the Future of Psychedelic
Medicine Communications

Strategic communications for a pioneering industry. KCSA delivers specialized PR, social media, and investor relations support for organizations advancing psychedelic medicine and mental health innovation.
KCSA’s Psychedelics and Mental Healthcare Practice provides comprehensive communications strategies for companies at the forefront of psychedelic-assisted treatment. We focus exclusively on organizations working toward regulated, clinical offerings to treat mental health conditions such as PTSD, depression, anxiety, and addiction.
Our work has earned national recognition—including a PRNEWS Platinum Award for our efforts in promoting the Psychedelic Science 2023 Conference. We help companies articulate their scientific credibility, build public and investor trust, and position themselves as responsible leaders in a transformative space. Through integrated campaigns and deep media relationships, we elevate our clients’ stories while navigating an evolving policy and cultural landscape.

This space is evolving fast

— and thoughtful, transparent communication can shape the future.

SELECTED WORKS

Carnival Cruises

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation
key landing page benchmarks
0 % ABOVE
key landing page benchmarks
0 % ABOVE
key landing page benchmarks
0 % ABOVE
key landing page benchmarks
0 % ABOVE

Carnival Cruises

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation
key landing page benchmarks
0 % ABOVE
key landing page benchmarks
0 % ABOVE
key landing page benchmarks
0 % ABOVE
key landing page benchmarks
0 % ABOVE

Carnival Cruises

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation
key landing page benchmarks
0 % ABOVE
key landing page benchmarks
0 % ABOVE
key landing page benchmarks
0 % ABOVE
key landing page benchmarks
0 % ABOVE
INDUSTRY INSIGHTS

INDUSTRY INSIGHTS

Wall Street is investing heavily in psychedelic therapies, with the market for psychedelic therapeutics valued at $3.5 billion in 2021 and expected to double by 2026, spurred by promising clinical trials.

North America leads the psychedelic medicine market, with the U.S. and Canada advancing research and regulatory support, and the region is expected to maintain its dominance with a projected CAGR of 13.2% from 2024 to 2032.

After 2 MDMA sessions, 54.2% of patients no longer met PTSD diagnostic criteria compared with 22.6% in the control group.

The psychedelic therapeutics market is valued at $2.2 billion in 2024 and is expected to reach $9.6 billion by 2034, with a CAGR of 15.6% from 2025 to 2034.

The U.S. psychedelic drugs market was valued at $4.51 billion in 2024 and is projected to reach $15.62 billion by 2032, growing at a CAGR of 16.8% during the forecast period.

Over 50% of millennials expressed interest in using psychedelics for mental health treatment, the highest among generational groups.

KEY CAPABILITIES

Lorem ipsum

  • Content Creation
  • Pitching
  • Reporter intros
  • Speaking Opportunities

Lorem ipsum

  • NewsJacking
  • Press Releases
  • Proactive Media Relations

Lorem ipsum

  • Thought Leadership
  • Expert Sourcing
  • Byline development

Lorem ipsum

  • Data Storytelling
  • Crisis Management
  • Trade Show Support

LETS TALK ABOUT YOUR NEXT STORY

Whether you’re launching something new, navigating change, or looking to strengthen your market presence—we’re here to help.

Reach out to start the conversation. We’d love to hear what you’re building.

KCSA
261 Madison Ave.
9th Floor New York, NY 10016

Instagram Facebook Twitter Linkedin
Ready to lead the conversation?
©2025 KCSA Strategic Communications. All Rights Reserved.